{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:10:38Z","timestamp":1793286638033,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Ophthalmology Practice and Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.aopr.2023.07.003","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T02:14:01Z","timestamp":1691201641000},"page":"159-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Research trends of worldwide ophthalmologic randomized controlled trials in the 21st century: A bibliometric study"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1015-9141","authenticated-orcid":false,"given":"Hao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.aopr.2023.07.003_bib1","first-page":"2420","article-title":"A\u00a0new approach to teaching the practice of medicine","volume":"268","author":"Evidence-based medicine","year":"1992","journal-title":"Jama. Nov 4"},{"issue":"7023","key":"10.1016\/j.aopr.2023.07.003_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","article-title":"Evidence based medicine: what it is and what it isn't","volume":"312","author":"Sackett","year":"1996","journal-title":"BMJ (Clinical research ed)."},{"issue":"23","key":"10.1016\/j.aopr.2023.07.003_bib3","first-page":"c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (Clinical research ed)","volume":"340","author":"Schulz","year":"2010","journal-title":"Mar"},{"issue":"12","key":"10.1016\/j.aopr.2023.07.003_bib4","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.ophtha.2015.06.012","article-title":"Evidence in ophthalmology: are we doing better?","volume":"122","author":"Bojikian","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.aopr.2023.07.003_bib5","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.12688\/f1000research.20673.1","article-title":"Randomized controlled trials in ophthalmology: a bibliometric study","volume":"8","author":"AlRyalat","year":"2019","journal-title":"F1000Research"},{"key":"10.1016\/j.aopr.2023.07.003_bib6","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fpubh.2019.00384","article-title":"Trends in shared decision-making studies from 2009 to 2018: a bibliometric analysis","volume":"7","author":"Lu","year":"2019","journal-title":"Frontiers in public health"},{"issue":"4","key":"10.1016\/j.aopr.2023.07.003_bib7","first-page":"18","article-title":"Mapping the worldwide trends on energy poverty research: a bibliometric analysis (1999-2019)","author":"Xiao","year":"2021","journal-title":"International journal of environmental research and public health"},{"key":"10.1016\/j.aopr.2023.07.003_bib8","first-page":"22","article-title":"Visualizing the knowledge structure and evolution of big data research in healthcare informatics. International journal of medical informatics","volume":"98","author":"Gu","year":"2017","journal-title":"Feb"},{"issue":"8","key":"10.1016\/j.aopr.2023.07.003_bib9","first-page":"391","article-title":"HistCite: a software tool for informetric analysis of citation linkage","volume":"57","author":"Garfield","year":"2006","journal-title":"NFD Information-Wissenschaft und Praxis"},{"key":"10.1016\/j.aopr.2023.07.003_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"Waltman","year":"2010","journal-title":"Scientometrics"},{"issue":"3","key":"10.1016\/j.aopr.2023.07.003_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/asi.20317","article-title":"CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"57","author":"Chen","year":"2006","journal-title":"Journal of the American Society for Information Science and Technology"},{"issue":"2","key":"10.1016\/j.aopr.2023.07.003_bib12","article-title":"Research trends of uveal melanoma: a bibliometric study and visualization analysis","volume":"4","author":"Wang","year":"2021","journal-title":"TMR cancer"},{"issue":"14","key":"10.1016\/j.aopr.2023.07.003_bib13","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"1 Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"The New England journal of medicine"},{"issue":"6","key":"10.1016\/j.aopr.2023.07.003_bib14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"2 the ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1016\/j.aopr.2023.07.003_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"3 the Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators","volume":"130","year":"2000","journal-title":"American journal of ophthalmology"},{"issue":"10","key":"10.1016\/j.aopr.2023.07.003_bib16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"4 Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Archives of ophthalmology (Chicago, Ill"},{"issue":"5","key":"10.1016\/j.aopr.2023.07.003_bib17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"5 reliability and validity of the ocular surface disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Archives of ophthalmology (Chicago, Ill"},{"issue":"12","key":"10.1016\/j.aopr.2023.07.003_bib18","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"6 photocoagulation for diabetic macular edema: early treatment diabetic retinopathy study report number 1 early treatment diabetic retinopathy study research group","volume":"103","year":"1985","journal-title":"Archives of Ophthalmology"},{"issue":"14","key":"10.1016\/j.aopr.2023.07.003_bib19","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"7 Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"The New England journal of medicine"},{"issue":"6","key":"10.1016\/j.aopr.2023.07.003_bib20","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archopht.1993.01090060119035","article-title":"8 the lens Opacities classification system III. The longitudinal study of cataract study group","volume":"111","author":"Chylack","year":"1993","journal-title":"Archives of ophthalmology (Chicago, Ill : 1960)"},{"issue":"6","key":"10.1016\/j.aopr.2023.07.003_bib21","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","article-title":"9 Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema","volume":"117","author":"Elman","year":"2010","journal-title":"Ophthalmology. Jun"},{"issue":"10","key":"10.1016\/j.aopr.2023.07.003_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","year":"1999","journal-title":"Archives of ophthalmology (Chicago, Ill : 1960)"},{"issue":"3","key":"10.1016\/j.aopr.2023.07.003_bib23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"2 TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"The ocular surface"},{"issue":"3","key":"10.1016\/j.aopr.2023.07.003_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"3 TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"The ocular surface"},{"issue":"4","key":"10.1016\/j.aopr.2023.07.003_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"6 Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE","volume":"119","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.aopr.2023.07.003_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archopht.116.4.521","article-title":"7 Evaluating new retinal imaging techniques","volume":"116","author":"Bressler","year":"1998","journal-title":"Archives of ophthalmology (Chicago, Ill"},{"issue":"3","key":"10.1016\/j.aopr.2023.07.003_bib27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"8 TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"The ocular surface"},{"issue":"3","key":"10.1016\/j.aopr.2023.07.003_bib28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"9 TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"The ocular surface"},{"issue":"1","key":"10.1016\/j.aopr.2023.07.003_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"10 low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.aopr.2023.07.003_bib30","first-page":"198","article-title":"1 photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials\u2014TAP report 2","volume":"119","author":"Group BmtoA-RMDWPTS","year":"2001","journal-title":"Archives of Ophthalmology"},{"issue":"27","key":"10.1016\/j.aopr.2023.07.003_bib31","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"9 Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"The New England journal of medicine"},{"issue":"5","key":"10.1016\/j.aopr.2023.07.003_bib32","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"10 global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.aopr.2023.07.003_bib33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"11 efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology. Apr"},{"issue":"9","key":"10.1016\/j.aopr.2023.07.003_bib34","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ophtha.2008.06.015","article-title":"A\u00a0randomized trial comparing intravitreal triamcinolone acetonide and focal\/grid photocoagulation for diabetic macular edema","volume":"115","author":"13","year":"2008","journal-title":"Ophthalmology. Sep"},{"issue":"11","key":"10.1016\/j.aopr.2023.07.003_bib35","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/OPX.0000000000000036","article-title":"14 Multifocal contact lens myopia control","volume":"90","author":"Walline","year":"2013","journal-title":"Optometry and vision science"},{"issue":"10","key":"10.1016\/j.aopr.2023.07.003_bib36","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.ophtha.2005.06.007","article-title":"15 A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema","volume":"112","author":"Cunningham","year":"2005","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.aopr.2023.07.003_bib37","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"16 the RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema","volume":"118","author":"Mitchell","year":"2011","journal-title":"Ophthalmology. Apr"},{"issue":"6","key":"10.1016\/j.aopr.2023.07.003_bib38","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ophtha.2010.10.035","article-title":"17 Effect of dual-focus soft contact lens wear on axial myopia progression in children","volume":"118","author":"Anstice","year":"2011","journal-title":"Ophthalmology. Jun"},{"issue":"4","key":"10.1016\/j.aopr.2023.07.003_bib39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ophtha.2006.12.028","article-title":"18 Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up","volume":"114","author":"Arevalo","year":"2007","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.aopr.2023.07.003_bib40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2003.05.037","article-title":"19 Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial","volume":"111","author":"Massin","year":"2004","journal-title":"Ophthalmology. Feb"},{"issue":"9975","key":"10.1016\/j.aopr.2023.07.003_bib41","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"20 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial","volume":"385","author":"Garway-Heath","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.aopr.2023.07.003_bib42","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ophtha.2010.03.045","article-title":"21 A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2","volume":"117","author":"Michaelides","year":"2010","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.aopr.2023.07.003_bib43","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"22 Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results","volume":"119","author":"Martin","year":"2012","journal-title":"Ophthalmology. Jul"},{"issue":"3","key":"10.1016\/j.aopr.2023.07.003_bib44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"1 TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"The ocular surface"},{"issue":"2","key":"10.1016\/j.aopr.2023.07.003_bib45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"3 five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology. Feb"},{"issue":"1","key":"10.1016\/j.aopr.2023.07.003_bib46","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1016\/S0161-6420(99)00085-8","article-title":"Evidence-based ophthalmology series and content-based continuing medical education for the journal","volume":"107","author":"Minckler","year":"2000","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.aopr.2023.07.003_bib47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11186-019-09352-6","article-title":"The rise of randomized controlled trials (RCTs) in international development in historical perspective","volume":"48","author":"de Souza Le\u00e3o","year":"2019","journal-title":"Theory and Society"},{"issue":"10199","key":"10.1016\/j.aopr.2023.07.003_bib48","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(19)31256-5","article-title":"High-quality evidence to inform clinical practice","volume":"394","author":"Fanaroff","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.aopr.2023.07.003_bib49","first-page":"249","article-title":"Biomedical research productivity: factors across the countries. International journal of technology assessment in health care","volume":"19","author":"Rahman","year":"2003","journal-title":"Winter"},{"key":"10.1016\/j.aopr.2023.07.003_bib50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fpubh.2020.00291","article-title":"Longevity and economic growth in China and India using a newly developed bootstrap ARDL model","volume":"8","author":"Lin","year":"2020","journal-title":"Frontiers in public health"},{"key":"10.1016\/j.aopr.2023.07.003_bib51","article-title":"Economic growth, income inequality and life expectancy in China","volume":"256","author":"Luo","year":"1982","journal-title":"Social science & medicine"},{"key":"10.1016\/j.aopr.2023.07.003_bib52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.socscimed.2018.11.031","article-title":"Economic growth and mental health in 21st century China","volume":"220","author":"Wang","year":"1982","journal-title":"Social science & medicine"},{"key":"10.1016\/j.aopr.2023.07.003_bib53","volume":"2020","author":"Weng","year":"2020"},{"issue":"12","key":"10.1016\/j.aopr.2023.07.003_bib54","doi-asserted-by":"crossref","first-page":"e682","DOI":"10.1016\/S2468-2667(20)30254-1","article-title":"Prevalence and causes of vision loss in China from 1990 to 2019: findings from the global burden of disease study 2019","volume":"5","author":"Xu","year":"2020","journal-title":"The Lancet Public health"},{"issue":"2","key":"10.1016\/j.aopr.2023.07.003_bib55","first-page":"e106","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet Global health","volume":"2","author":"Wong","year":"2014","journal-title":"Feb"},{"issue":"2","key":"10.1016\/j.aopr.2023.07.003_bib56","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","article-title":"Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study","volume":"9","year":"2021","journal-title":"The Lancet Global health. Feb"},{"issue":"2","key":"10.1016\/j.aopr.2023.07.003_bib57","first-page":"e144","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. The Lancet Global health","volume":"9","year":"2021","journal-title":"Feb"},{"issue":"10","key":"10.1016\/j.aopr.2023.07.003_bib58","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.mayocp.2013.04.026","article-title":"Why randomized controlled trials are needed to accept new practices: 2 medical worldviews","volume":"88","author":"Prasad","year":"2013","journal-title":"Mayo Clinic proceedings"},{"issue":"6","key":"10.1016\/j.aopr.2023.07.003_bib59","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.drudis.2016.05.001","article-title":"Anti-VEGF therapy in ophthalmology: a qualitative analysis of transformative drug development","volume":"21","author":"Caplan","year":"2016","journal-title":"Drug discovery today"},{"key":"10.1016\/j.aopr.2023.07.003_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100906","article-title":"Incomplete response to Anti-VEGF therapy in neovascular AMD: exploring disease mechanisms and therapeutic opportunities","volume":"82","author":"Mettu","year":"2021","journal-title":"Progress in retinal and eye research"},{"issue":"8","key":"10.1016\/j.aopr.2023.07.003_bib61","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa2204225","article-title":"Aflibercept monotherapy or bevacizumab first for diabetic macular edema","volume":"387","author":"Jhaveri","year":"2022","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.aopr.2023.07.003_bib62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2020.03.044","article-title":"Patient-reported burden of dry eye disease in the United States: results of an online cross-sectional survey","volume":"216","author":"Dana","year":"2020","journal-title":"American journal of ophthalmology"},{"key":"10.1016\/j.aopr.2023.07.003_bib63","first-page":"83","article-title":"Prevalence and risk factors of dry eye in 79,866 participants of the population-based Lifelines cohort study in The Netherlands. The ocular surface","volume":"19","author":"Vehof","year":"2021","journal-title":"Jan"},{"issue":"4","key":"10.1016\/j.aopr.2023.07.003_bib64","first-page":"1994","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Investigative ophthalmology & visual science","volume":"52","author":"Schaumberg","year":"2011","journal-title":"Mar"},{"issue":"6","key":"10.1016\/j.aopr.2023.07.003_bib65","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/ICO.0000000000001208","article-title":"Estimation of prevalence of meibomian gland dysfunction in Japan","volume":"36","author":"Amano","year":"2017","journal-title":"Cornea. Jun"},{"issue":"5","key":"10.1016\/j.aopr.2023.07.003_bib66","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.aopr.2023.07.003_bib67","first-page":"981","article-title":"Mask-associated dry-eye in COVID-19 pandemic: a case report and review of the literature","volume":"72","author":"Ali Momin","year":"2022","journal-title":"JPMA The Journal of the Pakistan Medical Association"},{"issue":"5","key":"10.1016\/j.aopr.2023.07.003_bib68","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4103\/ijmr.IJMR_1369_20","article-title":"COVID-19 pandemic from an ophthalmology point of view","volume":"151","author":"Gupta","year":"2020","journal-title":"The Indian journal of medical research"},{"issue":"3","key":"10.1016\/j.aopr.2023.07.003_bib69","first-page":"495","article-title":"A\u00a0narrative review of current understanding and classification of dry eye disease with new insights on the impact of dry eye during the COVID-19 pandemic. Ophthalmology and therapy","volume":"10","author":"Barabino","year":"2021","journal-title":"Sep"},{"issue":"3","key":"10.1016\/j.aopr.2023.07.003_bib70","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamaophthalmol.2020.6239","article-title":"Progression of myopia in school-aged children after COVID-19 home confinement","volume":"139","author":"Wang","year":"2021","journal-title":"JAMA ophthalmology. Mar"},{"key":"10.1016\/j.aopr.2023.07.003_bib71","article-title":"Myopia incidence and lifestyle changes among school children during the COVID-19 pandemic: a population-based prospective study","author":"Zhang","year":"2021","journal-title":"The British journal of ophthalmology"},{"issue":"2","key":"10.1016\/j.aopr.2023.07.003_bib72","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/ajcn\/nqaa139","article-title":"A\u00a0novel botanical formula improves eye fatigue and dry eye: a randomized, double-blind, placebo-controlled study","volume":"112","author":"Kan","year":"2020","journal-title":"The American journal of clinical nutrition"},{"key":"10.1016\/j.aopr.2023.07.003_bib73","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211056710","article-title":"Adverse events of rituximab in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis","volume":"14","author":"Wang","year":"2021","journal-title":"Therapeutic advances in neurological disorders"},{"issue":"1","key":"10.1016\/j.aopr.2023.07.003_bib74","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12967-019-1810-x","article-title":"Emerging trends and research foci in gastrointestinal microbiome","volume":"17","author":"Huang","year":"2019","journal-title":"Journal of translational medicine"},{"issue":"3","key":"10.1016\/j.aopr.2023.07.003_bib75","doi-asserted-by":"crossref","DOI":"10.2196\/12625","article-title":"Detecting the interdisciplinary nature and topic hotspots of robotics in surgery: social network analysis and bibliometric study","volume":"21","author":"Shen","year":"2019","journal-title":"Journal of medical Internet research"}],"container-title":["Advances in Ophthalmology Practice and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667376223000215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667376223000215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:24:23Z","timestamp":1762644263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667376223000215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2667376223000215"],"URL":"https:\/\/doi.org\/10.1016\/j.aopr.2023.07.003","relation":{},"ISSN":["2667-3762"],"issn-type":[{"value":"2667-3762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research trends of worldwide ophthalmologic randomized controlled trials in the 21st century: A bibliometric study","name":"articletitle","label":"Article Title"},{"value":"Advances in Ophthalmology Practice and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aopr.2023.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of Zhejiang University Press.","name":"copyright","label":"Copyright"}]}}